Diversify Advisory Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
+33,976
New +$2.32M 0.05% 314
2026
Q1
Sell
-8,573
Closed -$610K 482
2025
Q4
$610K Buy
8,573
+832
+11% +$56K 0.02% 540
2025
Q3
$512K Buy
7,741
+812
+12% +$53.9K 0.02% 557
2025
Q2
$444K Buy
6,929
+727
+12% +$41.4K 0.02% 577
2025
Q1
$377K Buy
6,202
+377
+6% +$21.9K 0.02% 423
2024
Q4
$308K Buy
5,825
+494
+9% +$25.3K 0.02% 479
2024
Q3
$275K Buy
5,331
+418
+9% +$24K 0.01% 524
2024
Q2
$260K Sell
4,913
-3,418
-41% -$150K 0.01% 544
2024
Q1
$344K Buy
+8,331
New +$312K 0.02% 505

Other funds holding HALO

Diversify Advisory Services's HALO Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Halozyme (HALO) in Q2 2026: 33,976 shares worth $2.77M. The stake represents 0.05% of the portfolio and ranks #314 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in HALO as recently as Q4 2025.

Diversify Advisory Services first reported a position in HALO in Q1 2024 and has held it in 9 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Diversify Advisory Services held 33,976 shares of Halozyme worth $2.77M as of Q2 2026.
  • Halozyme was a new Diversify Advisory Services position in Q2 2026.
  • Halozyme made up 0.05% of Diversify Advisory Services's portfolio in Q2 2026, its #314 holding.
  • Diversify Advisory Services first reported a position in Halozyme in Q1 2024 and has held it in 9 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.